(NU/1433-37) NewCo: The Provision of Business Consultancy to Assist Commercialisation of University Research.

Newcastle University · Awarded

Buyer
Newcastle University
Status
Awarded
Country
United Kingdom
Region
England
Sector
Professional Services
Reference
FaT-ocds-h6vhtk-03719a
Published
2022-09-30
Deadline
2026-04-27

Tender summary

Cancer and neurodegenerative diseases represent major unmet medical needs. It is estimated that approximately 20% of oncogenes are transcription factors (TFs) and many are critical for carcinogenesis. The global Cancer Drugs market was valued at US$92Bn in 2019 and is expected to reach US$124Bn by the end of 2026. The global neurodegenerative diseases drugs market size was valued at US$35.5Bn Million in 2018 and is projected to reach US$63Bn by the end of 2026. Specifically, we plan to target three cancer related TFs, (ATF4 CREB, and ID1) which are implicated in a range of cancer types that…

This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.

Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.

Register for full access

IT tenders · Construction tenders · Sitemap